Perrigo (NYSE:PRGO) Issues FY 2022 Earnings Guidance

Perrigo (NYSE:PRGO – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided EPS guidance of $2.30-$2.40 for the period. The company issued revenue guidance of $4.49 billion-$4.53 billion, compared to the consensus revenue estimate of $4.49 billion.

Separately, StockNews.com began coverage on shares of Perrigo in a research report on Thursday, March 31st. They issued a hold rating on the stock.

Shares of PRGO stock opened at $39.86 on Wednesday. Perrigo has a 1 year low of $31.32 and a 1 year high of $50.90. The firm’s 50 day moving average is $36.32 and its 200-day moving average is $37.58. The firm has a market capitalization of $5.36 billion, a price-to-earnings ratio of -61.32 and a beta of 1.02. The company has a current ratio of 4.01, a quick ratio of 2.97 and a debt-to-equity ratio of 0.69.

Perrigo (NYSE:PRGO – Get Rating) last announced its earnings results on Wednesday, May 11th. The company reported $0.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.09). Perrigo had a positive return on equity of 4.88% and a negative net margin of 2.07%. During the same quarter last year, the business earned $0.50 EPS. On average, equities research analysts forecast that Perrigo will post 2.31 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 21st. Investors of record on Friday, June 3rd will be issued a $0.26 dividend. The ex-dividend date of this dividend is Thursday, June 2nd. This represents a $1.04 annualized dividend and a yield of 2.61%. Perrigo’s dividend payout ratio is currently -160.00%.

In related news, EVP Thomas Farrington sold 24,485 shares of the stock in a transaction that occurred on Monday, March 14th. The shares were sold at an average price of $37.13, for a total value of $909,128.05. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Ronald Craig Janish sold 3,954 shares of the company’s stock in a transaction that occurred on Monday, March 7th. The shares were sold at an average price of $36.73, for a total transaction of $145,230.42. The disclosure for this sale can be found here. Corporate insiders own 0.80% of the company’s stock.

A number of large investors have recently modified their holdings of the business. Thrivent Financial for Lutherans increased its position in shares of Perrigo by 0.9% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,273 shares of the company’s stock worth $1,372,000 after acquiring an additional 322 shares in the last quarter. Comerica Bank lifted its stake in Perrigo by 1.4% in the fourth quarter. Comerica Bank now owns 61,833 shares of the company’s stock valued at $2,387,000 after acquiring an additional 830 shares during the last quarter. Covestor Ltd lifted its stake in shares of Perrigo by 5,903.6% during the 1st quarter. Covestor Ltd now owns 1,681 shares of the company’s stock worth $65,000 after buying an additional 1,653 shares during the last quarter. Yousif Capital Management LLC lifted its stake in shares of Perrigo by 2.6% during the 1st quarter. Yousif Capital Management LLC now owns 69,672 shares of the company’s stock worth $2,677,000 after buying an additional 1,752 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in shares of Perrigo by 25,300.0% during the 1st quarter. Canada Pension Plan Investment Board now owns 2,540 shares of the company’s stock worth $98,000 after buying an additional 2,530 shares during the last quarter. 91.25% of the stock is owned by hedge funds and other institutional investors.

About Perrigo (Get Rating)

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International.

Recommended Stories